Physician profile
Mandeep Acharya
NPI 1366778540
$1,767.51
in general payments reported to CMS, 2019-2025
22 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $144 · 2021: $16.83 · 2022: $306 · 2023: $334 · 2024: $549 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $304.69 | 2019-2025 | Freestyle Libre 3, Eterna |
| Novo Nordisk INC | $191.17 | 2020-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $176.97 | 2020-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $163.21 | 2020-2024 | Breztri, Airsupra, Farxiga |
| Baxter Healthcare | $136.40 | 2022 | |
| Sanofi-Aventis U.S. LLC | $113.21 | 2020-2025 | |
| Glaxosmithkline, LLC. | $98.36 | 2020-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.90 | 2019 | |
| Exact Sciences Corporation | $88.32 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $66.32 | 2023-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.80 | 2020-2024 | Xifaxan, Trulance |
| Lilly USA, LLC | $57.99 | 2021-2024 | Mounjaro |
| Pfizer INC. | $35.57 | 2023-2024 | |
| Medtronic, INC. | $34.57 | 2023-2024 | Venaseal |
| Dynavax Technologies Corporation | $25.50 | 2025 | Heplisav-B |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.75 | 2024 | Jardiance |
| Itamar Medical INC | $19.15 | 2024 | Watchpatone |
| Echosens North America, INC. | $17.37 | 2024 | Fibroscan |
| Phadia US INC. | $15.72 | 2023 | Immunocap |
| Vbi Vaccine (Delaware) INC. | $15.61 | 2023 | Prehevbrio |
| Si-Bone, INC. | $14.86 | 2019 | |
| Abbvie INC. | $14.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandeep Acharya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.